Back to search
FDAFDA · Food and drugs·Recall number Z-0735-2022

VITROS Chemistry Products VersaTips, Catalog No. 6801715 A VersaTip sales unit is composed of 1000 tips per box.

Published March 16, 2022 · Recall initiated: December 10, 2021

Summary

FDA records medical device Class II recall Z-0735-2022, published March 16, 2022 and initiated December 10, 2021. Recalling firm: Ortho-Clinical Diagnostics, Inc.; Status: Ongoing; Reported quantity: 4125 units; Lot: UDI 10758750006786 Lot 1039734. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The lot has a shape deformity which may lead to a 16% reduction in the volume of the sample or reagent dispensed. In cases where the error is not detected and the affected results are not suppressed, clinical impact may include reduced drug dosage, or false positive or false negative results for bloodborne infectious disease assays when sample results are close to the cut-off value.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ortho-Clinical Diagnostics, Inc.
Distributor
Domestic distribution nationwide. Foreign distribution to Canada.
Lot
UDI 10758750006786 Lot 1039734
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was VITROS Chemistry Products VersaTips, Catalog No. 6801715 A VersaTip sales unit is composed of 1000 tips per box. recalled?

Yes. FDA published recall Z-0735-2022 on March 16, 2022. Reported hazard: The lot has a shape deformity which may lead to a 16% reduction in the volume of the sample or reagent dispensed. In cases where the error is not detected and the affected results are not suppressed, clinical impact may include reduced drug dosage, or false positive or false negative results for bloodborne infectious disease assays when sample results are close to the cut-off value.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit